Medicare AdvantageCoverageMedium impact
Genetic Testing for Hereditary Cancer - Medicare Advantage (Revised)
Humana·Oncology, Genetics, Family Medicine +1 more·Medicare Advantage
Effective date
May 1, 2026
We identified it
Jun 24, 2026
Summary
Humana Medicare Advantage has updated their genetic testing policy for hereditary cancer, effective May 1, 2026. The policy provides comprehensive coverage criteria for genetic testing across multiple cancer types including melanoma, gastric cancer, neuroendocrine tumors, and renal cell carcinoma syndromes.
Action Required
Before May 1, 2026: Review and update prior authorization protocols for hereditary cancer genetic testing to align with Humana's revised coverage criteria. Billing team should familiarize themselves with the specific genetic conditions covered (CDKN2A, CDK4, BAP1, CDH1, MEN1, RET, CDKN1B genes) and ensure documentation requirements match the updated policy guidelines for each cancer syndrome type.